Terminated OBSERVATIONAL NCT05372523

Senseye's OBCI Diagnostic Tool for PTSD

Pilot Investigation of Senseye's Ocular Brain-Computer Interface (OBCI) for Diagnosis of Adult With Post-Traumatic Stress Disorder (PTSD)

Sponsor: Senseye, Inc.

Conditions PTSD

Interventions CAPS-5 Assessment Senseye OBCI

Updated 4 times since 2022 Last updated: Apr 10, 2023 Started: Apr 25, 2022 Primary completion: Jan 11, 2023 Completion: Jan 11, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

No participants completed study

Other PTSD trials with similar outcome

Browse all PTSD trials

This observational or N/A phase trial investigates PTSD and is currently terminated or withdrawn. Senseye, Inc. leads this study, which shows 4 recorded versions since 2022 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Terminated
Jul 2024 — Sep 2024 [monthly]

Terminated
May 2023 — Jul 2024 [monthly]

Terminated

Status: Recruiting → Terminated
Jun 2022 — May 2023 [monthly]

Recruiting

First recorded

Apr 2022

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Senseye, Inc.

Data source: Senseye, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Sylmar, United States